StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Equities researchers at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued on Friday. The firm set a “hold” rating on the stock.

Retractable Technologies Price Performance

RVP stock opened at $0.76 on Friday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. The firm has a 50 day moving average price of $0.87 and a 200-day moving average price of $1.02. Retractable Technologies has a 52-week low of $0.71 and a 52-week high of $1.34. The firm has a market capitalization of $22.81 million, a price-to-earnings ratio of -1.25 and a beta of 2.06.

Retractable Technologies (NYSE:RVP) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. The firm had revenue of $6.03 million for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.

Insider Transactions at Retractable Technologies

In other Retractable Technologies news, CEO Thomas J. Shaw acquired 71,422 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The shares were bought at an average cost of $0.82 per share, with a total value of $58,566.04. Following the completion of the transaction, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders acquired 182,416 shares of company stock worth $164,400 over the last quarter. 54.60% of the stock is currently owned by insiders.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.